Noevir Holdings Co., Ltd.

4928

JP3760450001

Personal Products

Market Closed - Japan Exchange Other stock markets 07:00:00 17/05/2024 BST			5-day change	1st Jan Change
5,270 ^JPY	-0.57%		-0.38%	+2.53%

05-09	Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024	CI
2023	Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024	CI

Noevir Holdings Co., Ltd. authorizes a Buyback Plan.

November 06, 2017

The Board of Directors of Noevir Holdings Co., Ltd. has authorized a buyback plan on November 7, 2017.

Latest news about Noevir Holdings Co., Ltd.

Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024	05-09	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024	11-07	CI
Noevir Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended September 30, 2023, Payable on December 11, 2023	11-07	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	11-07	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023	07/08/23	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	07/08/23	CI
Noevir Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023	10/05/23	CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023	10/05/23	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023	10/05/23	CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023	07/02/23	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023	07/02/23	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023	10/11/22	CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023	10/11/22	CI
Noevir Holdings Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended September 30, 2022, Payable on December 09, 2022	10/11/22	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022	04/08/22	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2022	04/08/22	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022	11/05/22	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022	11/05/22	CI
Noevir Holdings Co., Ltd. Provides Earnings Guidance for the Six Months Ending March 2022 and for the Year Ending September 2022	08/02/22	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022	08/02/22	CI
FACTBOX-Japanese companies opening COVID-19 vaccination sites amid slow national rollout	04/06/21	RE
An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. from Takashi Okura.	02/08/20	CI
Noevir Holdings Co., Ltd. Announces Distribution	18/11/19	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2019	13/08/19	CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending September 30, 2019	13/08/19	CI

Chart Noevir Holdings Co., Ltd.

Duration

Period

More charts

Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.

Sector

Personal Products

Calendar

29/07/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Noevir Holdings Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

5,270 JPY

Average target price

5,730 JPY

Spread / Average Target

+8.73%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
NOEVIR HOLDINGS CO., LTD.	+2.53%	1.17B
L'ORÉAL	-0.68%	264B
KAO CORPORATION	+19.72%	20.89B
GALDERMA GROUP AG	0.00%	19.67B
SHISEIDO COMPANY, LIMITED	+15.62%	12.52B
COTY INC.	-14.17%	9.53B
AMOREPACIFIC CORPORATION	+19.93%	8.03B
PROYA COSMETICS CO.,LTD.	+10.20%	6.01B
NATURA &CO HOLDING S.A.	-2.43%	4.49B
INTER PARFUMS, INC.	-13.55%	4.01B

Cosmetics & Perfumes